Related Experiment Video
Updated: Jun 4, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
Published on: September 30, 2025
Low-density lipoprotein cholesterol goal attainment in high-risk family medicine patients
Joseph P Vande Griend1, Joseph J Saseen
1University of Colorado Denver, School of Pharmacy, 12631 East 17th Ave, Room 1411, Aurora, CO 80045 USA.
Insights
Defining "very high risk" for LDL-C goals varied significantly among patients with atherosclerotic vascular disease. Despite varied definitions, the rates of achieving a low-density lipoprotein-cholesterol (LDL-C) goal of <70mg/dl remained similar.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Risk Stratification
Background:
- The Adult Treatment Panel III guideline suggests a low-density lipoprotein-cholesterol (LDL-C) goal of <100mg/dl for patients with coronary heart disease or risk equivalence.
- An optional LDL-C goal of <70mg/dl is recommended for patients deemed "very high risk," but this category lacks clear definition, leading to varied clinical interpretations.
Purpose of the Study:
- To define the
Main Methods:
- Five distinct definitions of "very high risk" were developed to assess eligibility for an LDL-C goal of <70mg/dl.
- Medical records of 445 patients with coronary heart disease or risk equivalence were retrospectively evaluated over two years.
- Prevalence of "very high risk" and attainment of LDL-C <70mg/dl were assessed based on the five definitions.
Main Results:
- Prevalence of "very high risk" varied significantly by definition, ranging from 10.8% (atherosclerotic vascular disease [AVD] plus smoking) to 67.2% (All AVD).
- LDL-C <70mg/dl goal attainment rates showed no significant difference across the definitions, ranging from 26.7% to 46.3%.
- A significant portion of patients, even under the broadest definition (All AVD), did not meet the <70mg/dl LDL-C goal.
Conclusions:
- The classification of patients as "very high risk" is highly variable based on the definition used.
- Variability in defining "very high risk" did not appear to impact the rates of achieving the LDL-C <70mg/dl goal.
- Future guidelines, such as the forthcoming Adult Treatment Panel IV, should prioritize simplicity and clarity in defining patient risk and LDL-C goals for effective clinical application.
Background:
The Adult Treatment Panel III guideline recommends a low-density lipoprotein-cholesterol (LDL-C) goal of <100mg/dl for patients with coronary heart disease or risk equivalence (ie, other forms of atherosclerotic vascular disease [peripheral vascular disease, abdominal aortic aneurysm, cerebrovascular disease], diabetes). An optional LDL-C goal of <70mg/dl is recommended for patients considered "very high risk." This category is not well defined, and clinical interpretation of this category varies.
Methods:
To define this category and to determine eligibility for an LDL-C goal of <70mg/dl, 5 definitions of "very high risk" were developed. Patients with coronary heart disease or risk equivalence within the University of Colorado Family Medicine system over the course of 2 years were identified using International Classification of Diseases, 9th Revision codes (n=445). Their medical records were evaluated retrospectively. Patients characterized as "very high risk" according to the 5 definitions were assessed for LDL-C <70mg/dl goal attainment.
Results:
Twenty-seven patients did not have LDL-C measurements and were excluded. Using the 5 definitions, we discovered that prevalence as "very high risk" was 10.8% (atherosclerotic vascular disease [AVD] plus smoking), 19.1% (AVD plus diabetes), 21.5% (AVD plus metabolic syndrome plus uncontrolled hypertension or smoking), 47.1% (AVD plus metabolic syndrome), and 67.2% (All AVD), P < .0001. LDL-C <70mg/dl was attained in 26.7%, 46.3%, 31.1%, 39.1%, and 35.2%, respectively (P=.13).
Conclusion:
Classifying patients as "very high risk" is highly variable depending on individual definitions, but this does not appear to alter the rates of attaining an LDL-C goal of <70mg/dl. When the Adult Treatment Panel IV guidelines are developed and issued, simplicity and clarity will be important in assisting clinicians in defining patient risk and developing LDL-C goals.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...